(Q33783257)

29 July 2017

1 reference

title

Type I interferons and the Th1/Th2 paradigm (English)

1 reference

29 July 2017

Sinigaglia F

1

1 reference

PubMed ID

10579394

29 July 2017

D'Ambrosio D

series ordinal

2

1 reference

PubMed ID

10579394

29 July 2017

Rogge L

series ordinal

3

1 reference

29 July 2017

1 October 1999

1 reference

Developmental and Comparative Immunology

29 July 2017

1 reference

29 July 2017

23

1 reference

29 July 2017

657-663

1 reference

29 July 2017

7-8

1 reference

Functional diversity of helper T lymphocytes

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Enhanced NK cell activity in mice injected with interferon and interferon inducers

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon-alpha for the hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon-alpha for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Effects of interferon-alpha-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Jaks and STATs: biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Developmental commitment to the Th2 lineage by extinction of IL-12 signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Balancing the Th1/Th2 concept in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Mechanisms of interferon beta action in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0145-305X%2899%2900039-7

7 January 2021

10.1016/S0145-305X(99)00039-7

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10579394